New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 3, 2012
05:55 EDTSQNMSequenom concerns should alleviate with publication, says Piper Jaffray
Piper Jaffray believes the Genetics in Medicine article showing Sequenom's MaterniT21's ability to accurately detect trisomy 13 and 18 should alleviate concerns of the test's ability to detect rarer chromosomal abnormalities. The firm keeps an Overweight rating on Sequenom shares with a $6.25 price target.
News For SQNM From The Last 14 Days
Check below for free stories on SQNM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 16, 2014
10:44 EDTSQNMSequenom lost Inter Partes Review to Ariosa, says Piper Jaffray
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use